Learning Objectives:

1. Describe different subtypes of diffuse midline gliomas
2. Describe how the cell-of-origin may impact tumorigenesis
3. Describe how preclinical models can help guide future clinical trials.

Session date: 
11/29/2023 - 7:30am to 8:30am CST
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Oren J Becher, MD